RxDoctor Payments Data

Ellen Drexler

Neurology · Brooklyn, NYNPI 1952301855

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,900 of the $5,915 with a category attached, or 65.9%. AbbVie accounts for 84.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $5,157 and has fallen 98.6% since, to $70 in 2021.

$5,915in general payments, 2019–2025

Across 57 payments — averaging $103.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Amgen$124
  • Teva Pharmaceuticals USA, Inc.$107
  • Novartis$79
  • MDD US Operations, LLC$69
  • Biogen$66
  • plus $454 from 16 others

What the payments were for

  • Speaking & faculty fees$3,90066%
  • Travel & lodging$71312%
  • Food & beverage$1,25921%
  • Education$431%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,915 in reported general payments places this provider in the 70th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Other neurology in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →